Capping a whirlwind of summer activity that included senior management additions, a steady decline in stock price, and an approved plan to be acquired by Canadian company Canopy Growth, Acreage Holdings (CSE: ACRG.U; OTCQX: ACRGF) will kick off the fall with a string of business conference appearances. 

First up, members of the Acreage team will join Canopy Growth and Constellation Brands at the Barclays Global Consumer Staples Conference on September 4 at the InterContinental Boston.  

The trio of interconnected companies will host a Q & A session about the cannabis industry and their plan for Canopy to acquire Acreage after marijuana use is eventually legalized nationwide in the United States. 

That conference is shaping up as a destination point for North American cannabis businesses this year, as it will also include an appearance by Cronos Group Inc. (TSX: CRON; Nasdaq: CRON) Chief Executive Officer Mike Gorenstein as well as executives from Tilray (Nasdaq: TLRY). 

Following the Boston appearance, Acreage CEO Kevin Murphy is then scheduled to attend the Toronto MJBizConINT’L the next day alongside Mark Zekulin from Canopy to discuss the consolidation of hemp and cannabis operations. 

The remaining weeks of September will then see a trio of Acreage conferences, with upper management speaking at or attending these events: 

  • Eight Capital’s Global Cannabis Conference – Toronto (Shangri-La Hotel), September 19 
  • The C3 Canna Summit – New York (Union League Club), September 24, taking place as part of the United Nations Assembly Week with government and business attendees 
  • Sidoti & Company’s Fall 2019 Conference – New York (Grand Central Hyatt), September 25 

With the cannabis industry on both sides of the border currently drowning in cheap stock with high dilution, major licensed producers have been keen to appear at high-profile business events and attract new partnerships. 

Acreage stock in particular is significantly down from highs in the mid $20 range last year, currently trading at $7.67, which is nearly $5 less than the price it was selling for just two weeks ago. 

In an effort to kickstart revenue and bring in new customer types as U.S. legalization efforts continue, Acreage is launching three new product lines including vaporizer cartridges, sublingual breath sprays, and high CBD tinctures. 

About Author

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.